4//SEC Filing
Ryali Sriram 4
Accession 0001209191-21-031905
CIK 0001305253other
Filed
May 10, 8:00 PM ET
Accepted
May 11, 8:32 PM ET
Size
5.4 KB
Accession
0001209191-21-031905
Insider Transaction Report
Form 4
Ryali Sriram
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-05-10+87,000→ 87,000 totalExercise: $8.49Exp: 2031-05-09→ Common Stock (87,000 underlying)
Footnotes (1)
- [F1]The option vests in equal monthly installments over 48 months measured from May 10, 2021 subject to Reporting Person's continuous service status as of each such date.
Documents
Issuer
Eiger BioPharmaceuticals, Inc.
CIK 0001305253
Entity typeother
Related Parties
1- filerCIK 0001762893
Filing Metadata
- Form type
- 4
- Filed
- May 10, 8:00 PM ET
- Accepted
- May 11, 8:32 PM ET
- Size
- 5.4 KB